Form 8-K/A Murray committee appointment

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K/A
(Amendment No. 1)

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  February 23, 2005

IDEXX LABORATORIES, INC.
(Exact name of registrant as specified in its charter)


Delaware 000-19271 01-0393723
(State or other jurisdiction of
incorporation or organization)
  (Commission File Number)   (IRS Employer
Identification No.)
 




One IDEXX Drive, Westbrook, Maine   04092
            (Address of principal executive offices)       (ZIP Code)  



(207) 856-0300
(Registrant’s telephone number, including area code)


Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):

[  ] Written communications purusant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ] Soliciting material purusant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ] Pre-commencement communications purusant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ] Pre-commencement communications purusant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.02    Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

        (d)     On February 23, 2005, IDEXX Laboratories, Inc. (the “Company”) filed a Current Report on Form 8-K reporting that the Company’s board of directors appointed Robert J. Murray as a director. At the time of the required filing, the board of directors had not yet determined on which committees Mr. Murray would serve.

        At the annual meeting held on May 18, 2005, the Company’s board of directors appointed Mr. Murray as Chairman of the compensation committee.

2


SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: May 19, 2005 IDEXX LABORATORIES, INC.
         
By: /s/ Conan R. Deady
Conan R. Deady
Vice President, General Counsel and Secretary

3